Discontinuation report ORCIPRENALINE
| Report ID | 108373 |
| Drug Identification Number | 02236783 |
| Brand name | ORCIPRENALINE |
| Common or Proper name | ORCIPRENALINE |
| Company Name | AA PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | ORCIPRENALINE SULFATE |
| Strength(s) | 2MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL |
| Packaging size | 250ML |
| ATC code | R03CB |
| ATC description | ADRENERGICS FOR SYSTEMIC USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-03-10 |
| Remaining supply date | 2020-03-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-03-11 | English | Compare |
| v2 | 2020-03-10 | French | Compare |
| v1 | 2020-03-10 | English | Compare |
Showing 1 to 3 of 3